A detailed history of Kistler Tiffany Companies, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 214 shares of DXCM stock, worth $17,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214
Previous 214 -0.0%
Holding current value
$17,171
Previous $24,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$84.98 - $122.67 $12,747 - $18,400
150 Added 234.38%
214 $24,000
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $3,263 - $6,378
48 Added 300.0%
64 $5,000
Q3 2021

Nov 10, 2021

SELL
$106.71 - $143.18 $533 - $715
-5 Reduced 23.81%
16 $9,000
Q2 2020

Jul 20, 2020

BUY
$62.68 - $105.34 $1,316 - $2,212
21 New
21 $9,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.